Skip to main content
NIH funding notice RFA-MH-21-106

Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)

Closed on February 9, 2021.

Posted
November 18, 2020
Close date
February 9, 2021
Activity codes
R21
Institutes taking part
NIMH, ORWH

The notices it replaced

Its page names no earlier notice: it is new, or it does not say.

Replaced by PAR-22-036.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
1
1 new
First-year cost
$233,250
Institutions
1
1 contact PI

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. UNIV OF NORTH CAROLINA CHAPEL HILL1

Most frequent study sections

  1. Special Emphasis Panel (ZMH1 ERB-N (07))1
1 award under RFA-MH-21-106 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2022Identifying neurophysiological mechanisms of susceptibility to estradiol fluctuation and irritability symptoms in the menopause transition: An experimental approach1R21MH128241-01Andersen, Elizabeth HelenGirdler, Susan S.UNIV OF NORTH CAROLINA CHAPEL HILL, NCFirst-year cost $233,250Study section ZMH1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-14-0.3.3. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.